Eigen Therapeutics Competitors and Similar CompaniesClear all

Eigen Therapeutics's competitors and similar companies include Bolt Biotherapeutics, EpiBiologics, Pluri Biotech and Eleven Tx.
Eigen Therapeutics
Eigen Therapeutics
Eigen Therapeutics is a biotechnology company that develops therapeutics for cancer.
Bolt Biotherapeutics
Bolt Biotherapeutics
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
EpiBiologics
EpiBiologics
EpiBiologics is a company that provides a protein degradation platform.
Pluri Biotech
Pluri Biotech
Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
Eleven Tx
Eleven Tx
Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics.
Founding Date
Founding Date
2021
Founding Date
2015
Founding Date
2022
Founding Date
2003
Founding Date
2020
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Redwood City, US HQ
Locations
Redwood City, US HQ
Locations
San Mateo, US HQ
Locations
Haifa, IL HQ
Potsdam, DE
Locations
Tel Aviv-Yafo, IL HQ
Cambridge, GB
Boston, US
Employees
Employees
10
Employees
5248% decrease
Employees
40
Employees
106
Employees
29
Valuation ($)
Valuation ($)
N/A
Valuation ($)
25.6 m
Valuation ($)
N/A
Valuation ($)
25.2 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$7.7m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$1.3m (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($33.4m) (FY, 2025)
Net income
N/A
Net income
($23.3m) (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 7m (over 3 years ago)
Latest funding round
N/A
Latest funding round
$ 50m (about 3 years ago)
Latest funding round
N/A
Latest funding round
$ 22m (almost 4 years ago)
Total funding raised
Total funding raised
$ 7m
Total funding raised
$ 177.5m
Total funding raised
$ 50m
Total funding raised
$ 78.4m
Total funding raised
$ 22m
For sources of this data, please see the company profile

View Company Profiles

Bolt Biotherapeutics
HQ
Redwood City, US
Employees
52↓ 48% decrease

Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.

View company
EpiBiologics
HQ
San Mateo, US
Employees
40

EpiBiologics is a company that provides a protein degradation platform.

View company
Pluri Biotech
HQ
Haifa, IL
Employees
106

Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.

View company
Eleven Tx
HQ
Tel Aviv-Yafo, IL
Employees
29

Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics.

View company